Cutler Group LP Pro Qr Therapeutics N.V. Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	BUY	$0.9 - $8.39 $90 - $839	100 Added 4.76%	2,200 $16,000
Q3 2021 Oct 26, 2021	BUY	$5.16 - $8.47 $1,548 - $2,541	300 Added 16.67%	2,100 $0
Q4 2020 Jan 21, 2021	BUY	$3.58 - $4.85 $4,296 - $5,820	1,200 Added 200.0%	1,800 $3,000
Q3 2020 Oct 27, 2020	SELL	$4.79 - $6.3 $32,093 - $42,210	-6,700 Reduced 91.78%	600 $2,000
Q2 2020 Jul 22, 2020	BUY	$4.5 - $6.53 $13,500 - $19,590	3,000 Added 69.77%	7,300 $16,000
Q1 2020 May 07, 2020	BUY	$5.25 - $9.9 $17,325 - $32,670	3,300 Added 330.0%	4,300 $11,000
Q4 2019 Feb 06, 2020	BUY	$5.84 - $10.51 $5,840 - $10,510	1,000 New	1,000 $0

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $199M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.